---  
layout: startup_page  
title: "Granza Bio"  
id: "granzabio.com"  
permalink: "/granzabiogranzabio.com07102024/"  
website: "https://www.granzabio.com/"  
funding_round: "Seed"  
funding_amount: "$7.14M"  
investors: "Felicis, Refactor, Y Combinator"  
about: "Granza Bio develops a novel drug delivery platform using \"attack particles\" from the immune system to target various diseases like cancer, autoimmune disorders, and infections. Their platform focuses on delivering therapeutic cargo to specific tissues, overcoming challenges in tropism, immunogenicity, and stability. This technology aims to transform the therapeutic landscape by offering the power of cellular therapies with the ease of antibody-based drugs."  
markets: "Biotechnology, Therapeutics, Immunology, Oncology, Drug Discovery"  
hq: "London, England, United Kingdom"  
founded_year: "2023"  
linkedin: "https://www.linkedin.com/company/granza-bio-yc-w24/"  
twitter: "https://twitter.com/GranzaBio"  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/granza-bio"  
pitchbook: "https://pitchbook.com/profiles/company/593005-33"  

date_display: "10-Jul-2024"  
date: "2024-07-10"

# SEO Optimization  
meta_title: "Granza Bio - Seed Funding ($7.14M)"  
meta_description: "Granza Bio, Granza Bio develops a novel drug delivery platform using \"attack particles\" from the immune system to target various diseases like cancer, autoimmun..."  
meta_keywords: "Granza Bio, Biotechnology, Therapeutics, Immunology, Oncology, Drug Discovery, Seed funding"  
canonical_url: "https://startup.projectstartups.com/granzabiogranzabio.com07102024/"  
---